Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,23 USD | +0,38 % | -3,24 % | -0,19 % |
Resumen de negocios
Número de empleados: 88
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Integrated Drug and Drug Delivery Solutions
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +14,31 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +14,31 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Maria Palasis
CEO | Chief Executive Officer | 59 | 01/01/15 |
Jason Cavalier
DFI | Director of Finance/CFO | 51 | 13/09/21 |
Richard Nieman
CTO | Chief Tech/Sci/R&D Officer | 61 | 11/07/22 |
Vineeta Belanger
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/19 |
John Bishop
CTO | Chief Tech/Sci/R&D Officer | 62 | 27/02/23 |
Ellen Cavaleri
IRC | Investor Relations Contact | - | 01/01/22 |
Ronan O’Brien
LAW | General Counsel | 52 | 16/10/23 |
Corinne Noyes
PRN | Corporate Officer/Principal | 56 | 01/09/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Harlan Waksal
CHM | Chairman | 71 | 16/02/22 |
W. Smith
BRD | Director/Board Member | 68 | 19/11/19 |
James Tobin
BRD | Director/Board Member | 79 | 07/03/22 |
C. Merrifield
BRD | Director/Board Member | 73 | 04/09/19 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 28/10/20 |
Michael Altman
BRD | Director/Board Member | 42 | 01/06/18 |
Maria Palasis
CEO | Chief Executive Officer | 59 | 01/01/15 |
Director/Board Member | 40 | 29/01/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 59 743 123 | 46 281 091 ( 77,47 %) | 0 | 77,47 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-0,19 % | 311 M | |
+4,09 % | 43,43 mil M | |
+47,81 % | 41,69 mil M | |
+9,63 % | 41,31 mil M | |
-10,92 % | 27,14 mil M | |
+9,46 % | 25,28 mil M | |
-24,87 % | 18,47 mil M | |
+29,75 % | 12,59 mil M | |
+1,42 % | 12,33 mil M | |
+7,83 % | 11,03 mil M |
- Bolsa de valores
- Acciones
- Acción LYRA
- Empresa Lyra Therapeutics, Inc.